Diffusion tensor imaging parameters’ changes of cerebellar hemispheres in Parkinson’s disease

Neuroradiology

Volumn 57, Issue 3, 2015, Pages 327-334

  Mormina, Enricomaria ^a   Arrigo, Alessandro ^a   Calamuneri, Alessandro ^b   Granata, Francesca ^a   Quartarone, Angelo ^b   Ghilardi, Maria F ^c   Inglese, Matilde ^c   Di Rocco, Alessandro ^c   Milardi, Demetrio ^a,d   Anastasi, Giuseppe P ^a   Gaeta, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c MOUNT SINAI HOSPITAL   (United States)

^d IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Diffusion tensor imaging; FA; MRI; Parkinson s disease; Probabilistic tractography

Indexed keywords

ADULT; ANTERIOR POSTERIOR AXIS; ARTICLE; CEREBELLUM; CEREBELLUM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; MIDDLE AGED; MIDDLE CEREBELLAR PEDUNCLE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUPERIOR CEREBELLAR PEDUNCLE; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER; CEREBELLAR DISEASES; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CEREBELLAR DISEASES; CEREBELLUM; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHITE MATTER;

EID: 84925496670     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-014-1473-5     Document Type: Article

References (53)

1. Lew M (2007) Overview of Parkinson’s disease. Pharmacotherapy 27(12 Pt 2):155S–160S
2. Damier P, Hirsch EC, Agid Y et al (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain 122(Pt 8):1437–1448
3. Blandini F, Nappi G, Tassorelli C et al (2000) Functional changes of the basal ganglia circuitry in Parkinson’s disease. Prog Neurobiol 62(1):63–88
4. Wu T, Hallett M (2013) The cerebellum in Parkinson’s disease. Brain 136(Pt 3):696–709
5. Yu H, Sternad D, Corcos DM et al (2007) Role of hyperactive cerebellum and motor cortex in Parkinson’s disease. Neuroimage 35(1):222–233
6. Jankovic J, Kapadia AS (2001) Functional decline in Parkinson disease. Arch Neurol 58(10):1611–1615
7. Nicoletti G, Lodi R, Condino F et al (2006) Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy. Brain 129(Pt 10):2679–2687
8. Kim HJ, Kim SJ, Kim HS et al (2013) Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson’s disease. Neurosci Lett 550:64–68
9. Gattellaro G, Minati L, Grisoli M et al (2009) White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 30(6):1222–1226
10. Schwarz ST, Abaei M, Gontu V et al (2013) Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin 3:481–488
11. Nicoletti G, Rizzo G, Barbagallo G et al (2013) Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 267(3):843–850
12. Embleton KV, Haroon HA, Morris DM et al (2010) Distortion correction for diffusion-weighted MRI tractography and fMRI in the temporal lobes. Hum Brain Mapp 31:1570–1587
13. Jones DK, Horsfield MA, Simmons A (1999) Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 42:515–525
14. Tournier JD, Calamante F, Connelly A (2007) Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage 35(4):1459–1472
15. Jones DK, Cercignani M (2010) Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed 23:803–820
16. Tournier JD, Calamante F, Connelly A (2012) MRtrix: diffusion tractography in crossing fiber regions. Int J Imaging Syst Technol 22(1):53–66
17. Pajevic S, Pierpaoli C (1999) Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn Reson Med 42:526–540
18. Descoteaux M, Deriche R, Knösche TR et al (2009) Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging 28:269–286
19. Tournier JD, Calamante F, Connelly A (2011) Effect of step size on probabilistic streamlines: implications for the interpretation of connectivity analysis. Proc Intl Soc Mag Reson Med 19:2019
20. Alexander DC, Barker GJ (2005) Optimal imaging parameters for fiber-orientation estimation in diffusion MRI. Neuroimage 27:357–367
21. Leemans A, Jeurissen B, Sijbers J et al (2009) ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. Proc Intl Soc Mag Reson Med 245:3537
22. Rosenblatt M (1956) Remarks on some nonparametric estimates of a density function. Ann Math Stat 27(3):832–837
23. Parzen E (1962) On estimation of a probability density function and mode. Ann Math Stat 33(3):1065–1076
24. Parker GJ, Luzzi S, Alexander DC et al (2005) Lateralization of ventral and dorsal auditory-language pathways in the human brain. Neuroimage 24:656–666
25. Lebel C, Beaulieu C (2009) Lateralization of the arcuate fasciculus from childhood to adulthood and its relation to cognitive abilities in children. Hum Brain Mapp 30:3563–3573
26. Ota M, Nakata Y, Ito K et al (2013) Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures. Comput Math Methods Med 2013:571289
27. Wang PS, Wu HM, Lin CP et al (2011) Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 53(7):471–481
28. Zhang K, Yu C, Zhang Y et al (2011) Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson’s disease. Eur J Radiol 77(2):269–273
29. Cochrane CJ, Ebmeier KP (2013) Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80(9):857–864
30. Alvarez-Linera J (2008) 3 T MRI: advances in brain imaging. Eur J Radiol 67(3):415–426
31. Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38(7):385–402
32. Vollmar C, O’Muircheartaigh J, Barker GJ et al (2010) Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0 T scanners. Neuroimage 51(4):1384–1394
33. Chung AW, Thomas DL, Ordidge RJ et al (2013) Diffusion tensor parameters and principal eigenvector coherence: relation to b-value intervals and field strength. Magn Reson Imaging 31(5):742–747
34. Wedeen VJ, Wang RP, Schmahmann JD et al (2008) Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage 41(4):1267–1277
35. Jbabdi S, Johansen-Berg H (2013) Tractography: where do we go from here? Brain Connect 1(3):169–183
36. Tournier JD, Yeh CH, Calamante F et al (2008) Resolving crossing fibres using constrained spherical deconvolution: validation using diffusion-weighted imaging phantom data. Neuroimage 42(2):617–625
37. Okada T, Miki Y, Fushimi Y et al (2006) Diffusion-tensor fiber tractography: intraindividual comparison of 3.0-T and 1.5-T MR imaging. Radiology 238(2):668–678
38. Tournier JD, Calamante F, Connelly A (2013) Determination of the appropriate b value and number of gradient directions for high-angular-resolution diffusion-weighted imaging. NMR Biomed 26(12):1775–1786
39. Gallagher DA, Schapira AH (2009) Etiopathogenesis and treatment of Parkinson’s disease. Curr Top Med Chem 9(10):860–868
40. Piao YS, Mori F, Hayashi S et al (2003) Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Acta Neuropathol 105(4):403–409
41. Wakabayashi K, Hayashi S, Yoshimoto M et al (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99(1):14–20
42. Mori F, Piao YS, Hayashi S et al (2003) Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 62(8):812–819
43. Beaulieu C (2014) The biological basis of diffusion anisotropy. In: Johansen-Berg H, Behrens TEJ (eds) Diffusion MRI. From quantitative measurements to in-vivo neuroanatomy. Elsevier, Amsterdam, pp 155–178
44. Beaulieu C, Does MD, Snyder RE et al (1996) Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magn Reson Med 36:627–631
45. Bartels AL, Leenders KL (2007) Neuroinflammation in the pathophysiology of Parkinson’s disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord 22(13):1852–1856
46. Bartels AL, Willemsen AT, Doorduin J et al (2010) [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson’s disease? Parkinsonism Relat Disord 16(1):57–59
47. Watson MB, Richter F, Lee SK et al (2012) Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol 237(2):318–334
48. Jellinger KA (2001) Cell death mechanisms in neurodegeneration. J Cell Mol Med 5(1):1–17
49. Tievsky AL, Ptak T, Farkas J (1999) Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 20(8):1491–1499
50. Nicoletti G, Tonon C, Lodi R et al (2008) Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson’s disease. Mov Disord 23(16):2370–2376
51. Blain CR, Barker GJ, Jarosz JM et al (2006) Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67(12):2199–2205
52. Rizzo G, Martinelli P, Manners D et al (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson’s disease. Brain 131(Pt 10):2690–2700
53. Parker GD, Marshall D, Rosin PL et al (2013) A pitfall in the reconstruction of fibre ODFs using spherical deconvolution of diffusion MRI data. Neuroimage 65:433–448